Neurology research network starts IRB review

June 2012
IRB Advisor;Jun2012, Vol. 12 Issue 6, p66
The article discusses NeuroNEXT, a network developed by the National Institute of Neurological Disorders and Strokes (NINDS). The network coordinates institutional review board (IRB) reviews for institutions across the country in order to conduct trails of neurological therapies. It explains how sites can decide to participate in a particular study by looking at the central IRB's (CIRB's) review. Included are the comments by Pearl O'Rourke, director of human research affairs for Partners.


Related Articles

  • LAWS RELATING TO INFORMED CONSENT IN CLINICAL TRIALS. Craig, Kathrine J. // Nursing Standard;8/21/2013, Vol. 27 Issue 51, p33 

    A letter to the editor is presented in response to an article by Andrew Pick et al. in the August 7, 2013 issue which was concerned with laws relating to informed consent in clinical research trials.

  • Ethical research with the mentally disordered. Arboleda-Flórez, Julio; Weisstub, David N.; Arboleda-Flórez, J; Weisstub, D N // Canadian Journal of Psychiatry;Jun1997, Vol. 42 Issue 5, p485 

    Because of concerns about competence and voluntariness, the mentally disordered constitute a vulnerable population in the context of nontherapeutic biomedical research and, as such, are in need of protection. Despite others' concern about protecting the mentally disordered, their decision-making...

  • Are you more than just your cells? Henrietta inspires an artist. Bradley, Peter // British Journal of Healthcare Assistants;Jan2014, Vol. 8 Issue 1, p40 

    The article features healthcare assistant (HCA) Helen Wilson-Roe, who confessed that being an HCA drives her creative force as an artist. Wilson-Roe's art projects includes her Rwanda work and her second great project that pays tribute to Henrietta Lacks. The personal background of Wilson-Roe...

  • In Plain Sight: A Solution to a Fundamental Challenge in Human Research. Shepherd, Lois; Riley, Margaret Foster // Journal of Law, Medicine & Ethics;Winter2012, Vol. 40 Issue 4, p970 

    The physician-researcher conflict of interest has thus far eluded satisfactory solution. Most attempts to deal with it focus on improving informed consent. But those attempts are not successful and may even make things worse. Research subjects are already voluntarily undertaking the risks of...

  • Research sites should update their disaster preparedness.  // Clinical Trials Administrator;Nov2011, Vol. 9 Issue 11, p121 

    The article discusses the need for disaster planning in research sites to avert unpredictable tornadoes, flooding and other natural disasters. It illustrates the example of the losses in the flood ridden institutional review board (IRB) office at the University of Texas Health Science Center...

  • Exempting All Minimal-Risk Research from IRB Review: Pruning or Poisoning the Regulatory Tree? ANANTH, MAHESH; SCHEESSELE, MICHAEL R. // IRB: Ethics & Human Research;Mar/Apr2012, Vol. 34 Issue 2, p9 

    No abstract available.

  • Realizing Informed Consent in Times of Controversy: Lessons from the SUPPORT Study. Morse, Robert J.; Wilson, Robin Fretwell // Journal of Law, Medicine & Ethics;Fall2016, Vol. 44 Issue 3, p402 

    An essay is presented concerning whether the promise of informed consent in medical law meets the standard envisioned by U.S. jurist Benjamin Cardozo in 1914 regarding the right of individuals to determine medical treatment and participation in medical research. It discusses the study known as...

  • OHRP letters focus on informed consent issues.  // IRB Advisor;Jun2013, Vol. 13 Issue 6, p63 

    The letter discusses the letters of determination sent by the Office for Human Research Protections (OHRP) of Rockville in Maryland, U.S. to University of Alabama (UAB) pertaining to allegations of noncompliance of a SUPPORT study. OHRP has alleged that the study was in violation of the...

  • Clinical Research Involving Minors in International and Serbian Regulations. PLANOJEVIĆ, Nina; ŽIVOJINOVIĆ, Dragica // Iranian Journal of Public Health;Jul2013, Vol. 42 Issue 7, p652 

    Background: Participation in clinical trials can be useful for the health of a person, in who it is conducted, but it does not have to be -- it can even be harmful. Therefore, primary motive to accept such risk is humanity and human wish to contribute to the progress of medicine; this is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics